Two Years of Experience with Abiraterone in Patients with Castration-Resistant Prostate Cancer - Indications before Chemotherapy

Simple item page
dc.contributor.authorRichter Igorcs
dc.contributor.authorDvořák Josefcs
dc.contributor.authorBartoš Jiřícs
dc.date.accessioned2020-06-08T09:42:41Z
dc.date.available10-12-2019en
dc.date.available2020-06-08T09:42:41Z
dc.date.issued2018cs
dc.date.updated29-06-2019en
dc.format.extent0cs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/155918
dc.language.isoczecs
dc.relation.ispartofseries0cs
dc.subjectCastration-Resistant Prostate Cancercs
dc.titleTwo Years of Experience with Abiraterone in Patients with Castration-Resistant Prostate Cancer - Indications before Chemotherapyen
dc.titleDvouletá zkušenost s abirateronem u pacientů s kastračně-rezistentním karcinomem prostaty 8211 indikace před podáním chemoterapiecs
local.identifier.publikace6550
Files
Collections